このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

The Effectiveness of an Occupation-Based Lifestyle Program in Individuals With Type 2 Diabetes

2026年9月28日 更新者:Sena Albay、Ankara Medipol University

This study aims to investigate the effect of an occupation-focused lifestyle program on occupational performance, self-management, occupational balance, diabetes symptoms, and quality of life in individuals with Type 2 diabetes.

Type 2 diabetes requires continuous daily management, yet conventional interventions often show limited long-term behavioral sustainability. Occupation-focused lifestyle interventions offer a holistic approach by addressing daily routines, self-management skills, and personal goals.

In this non-invasive, quasi-experimental study, participants aged 18-74 with Type 2 diabetes will be invited via social media announcements. Participants will be divided into an intervention group and a control group. The intervention group will receive an online, 5-module (8 sessions) Occupation-Focused Lifestyle Program via Zoom, covering diabetes awareness, problem-solving, stress management (mindfulness), energy conservation/physical activity, and goal review. The control group will receive an informative brochure after the intervention group completes the program. Outcomes will be measured online before and after the program using structured scales to evaluate changes in daily functioning, self-care, and overall well-being

調査の概要

状態

募集

条件

介入・治療

詳細な説明

Background and Rationale:

Type 2 diabetes mellitus accounts for 90-95% of diabetes cases worldwide and presents significant challenges in physical and psychosocial functioning. Effective management requires long-term lifestyle adaptations, including healthy eating, physical activity, blood glucose monitoring, medication adherence, problem-solving, and stress management. While traditional lifestyle interventions improve clinical indicators in the short term, their long-term behavioral sustainability can be limited. Occupation-focused occupational therapy interventions integrate diabetes self-management into daily habits and meaningful roles, offering a structured framework to improve quality of life and health outcomes.

Study Design and Population:

This study is a quasi-experimental controlled trial conducted online. The target population consists of individuals aged 18-74 who have been diagnosed with Type 2 diabetes for more than 12 months, have internet access for online sessions, and provide documented proof of their diagnosis. Sample size calculation using G*Power (alpha = 0.05, power = 0.80, effect size d = 0.8) determined a required total sample size of 42 participants (21 per group).

Intervention:

Participants in the intervention group will participate in an 8-session (60 minutes per session, twice weekly) online program via Zoom, structured into 5 modules:

Module 1: Awareness (Session 1): Education on diabetes management, identifying daily challenges, and establishing individual occupational priorities using the Canadian Occupational Performance Measure (COPM).

Module 2: Problem Solving (Sessions 2 & 3): Teaching structured problem-solving steps tailored to diabetes self-management and personal goals.

Module 3: Stress Management (Sessions 4 & 5): Training in mindfulness techniques (breath awareness, body scan, sensory awareness) and integrating them into daily routines.

Module 4: Energy Conservation and Physical Activity (Sessions 6 & 7): Instruction on activity-role balance, energy conservation principles, and embedding safe physical activities (walking, home exercises) into daily life.

Module 5: Goal Review and Sustainability (Session 8): Re-evaluating COPM goals, addressing barriers, and developing sustainable long-term strategies.

Participants in the control group will receive an informative educational brochure (covering diabetes awareness, problem-solving, physical activity, mindfulness, and energy conservation) upon completion of the intervention group's program.

Outcome Measures:

Data will be collected via Google Forms at baseline (pre-test) and post-intervention (post-test) using the following instruments:

Demographic and Health Information Form

Canadian Occupational Performance Measure (COPM): Evaluates occupational performance and satisfaction.

Diabetes Self-Management Questionnaire (DSMQ / DÖYS): Assesses self-care activities associated with glycemic control.

Occupational Balance Questionnaire (OBQ11-T / ARDA11-T): Measures satisfaction with the balance of daily activities and roles.

Diabetes Symptom Checklist (DSC / DBKLÖ): Evaluates the presence and burden of physical and psychological diabetes symptoms.

Short Form-36 Health Survey (SF-36): Measures health-related quality of life across 8 domains.

Program Satisfaction Survey: Evaluates intervention group feedback on program content, applicability, and online delivery.

Statistical Analysis:

Data analysis will be performed using SPSS (Version 26.0). Descriptive statistics will summarize participant characteristics. Within-group pre-post changes and between-group differences will be analyzed using parametric tests (paired t-test, independent samples t-test) or non-parametric tests (Wilcoxon signed-rank test, Mann-Whitney U test) depending on normality distributions, with significance set at p < 0.05.

研究の種類

介入

入学 (推定)

42

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究場所

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年~74年 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

  • Diagnosed with Type 2 Diabetes Mellitus for at least 12 months
  • Aged between 18 and 74 years
  • Ability to provide documented proof of Type 2 diabetes diagnosis (e.g., medical report or official documentation)
  • Having access to a smartphone, tablet, or computer with an internet connection to attend online Zoom sessions and complete online questionnaires -Voluntary agreement to participate in the study and submission of an online informed consent form

Exclusion Criteria:

  • Presence of severe diabetic complications that significantly impair independent daily function (e.g., severe proliferative retinopathy, end-stage renal disease, active foot ulcers, or severe diabetic neuropathy)
  • Cognitive impairment, acute psychiatric conditions, or sensory deficits (uncorrected visual or hearing impairments) that impede active participation in group sessions or online communication
  • Participation in another structured diabetes self-management program or lifestyle intervention trial simultaneously

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:非ランダム化
  • 介入モデル:並列代入
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
実験的:Intervention Group

Participants receive an online, 5-module (8 sessions, twice weekly, 60 minutes each via Zoom) Occupation-Focused Lifestyle Program. The program covers diabetes awareness, problem-solving, stress management (mindfulness), energy conservation/physical activity, and goal setting.

An online, 5-module (8 sessions, 60 minutes each, twice weekly via Zoom) intervention led by occupational therapy staff. The program incorporates diabetes awareness, structured problem-solving, stress management (mindfulness), energy conservation, safe physical activity integration, and goal setting using the Canadian Occupational Performance Measure (COPM)

介入なし:Control Group

Participants maintain their routine care during the study period. After the intervention group completes the program and post-tests, the control group receives an informative educational brochure covering the program topics.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Canadian Occupational Performance Measure (COPM)
時間枠:Baseline (Week 0) and Post-intervention (Week 4)

Assesses individual occupational performance and satisfaction in self-care, productivity, and leisure domains. Scores range from 1 to 10 for both subscales, with higher scores indicating higher self-perceived performance and satisfaction.

Baseline (Week 0) and Post-intervention (Week 4)
Diabetes Self-Management Questionnaire (DSMQ)
時間枠:Baseline (Week 0) and Post-intervention (Week 4)

Evaluates self-care behaviors related to glycemic control, where higher scores indicate better self-management practices.

Baseline (Week 0) and Post-intervention (Week 4)
Occupational Balance Questionnaire (OBQ11)
時間枠:Baseline (Week 0) and Post-intervention (Week 4)

Measures satisfaction with the balance of daily activities and roles, with higher scores reflecting greater occupational balance.

Baseline (Week 0) and Post-intervention (Week 4)
Diabetes Symptom Checklist-Revised (DSC-R)
時間枠:Baseline (Week 0) and Post-intervention (Week 4)

Evaluates the presence and perceived burden of diabetes-related physical and psychological symptoms.

Baseline (Week 0) and Post-intervention (Week 4)
Short Form-36 Health Survey (SF-36)
時間枠:Baseline (Week 0) and Post-intervention (Week 4)

Measures health-related quality of life across physical and mental health domains, with higher scores reflecting better health status.

Baseline (Week 0) and Post-intervention (Week 4)

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2026年9月1日

一次修了 (推定)

2026年11月1日

研究の完了 (推定)

2026年12月1日

試験登録日

最初に提出

2026年9月22日

QC基準を満たした最初の提出物

2026年9月28日

最初の投稿 (実際)

2026年9月29日

学習記録の更新

投稿された最後の更新 (実際)

2026年9月29日

QC基準を満たした最後の更新が送信されました

2026年9月28日

最終確認日

2026年9月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • 199

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

はい

IPD プランの説明

De-identified individual participant data collected during the trial will be available upon reasonable request from qualified researchers after publication of the primary study results. Requests should be directed to the principal investigator and require a methodologically sound proposal and a signed data access agreement to ensure participant confidentiality.

IPD 共有時間枠

Available upon reasonable request starting 6 months following the publication of the primary study results and ending 3 years after the publication date.

IPD 共有アクセス基準

Qualified academic researchers with a methodologically sound research proposal aimed at achieving the approved objectives will be granted access to de-identified individual participant data. Requesters must submit a formal research protocol and sign a Data Access Agreement with the principal investigator to ensure participant privacy and data security.

IPD 共有サポート情報タイプ

  • STUDY_PROTOCOL
  • ANALYTIC_CODE

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。